PDF herunterladen
Semin Liver Dis 2009; 29(1): 040-052
DOI: 10.1055/s-0029-1192054
© Thieme Medical Publishers

Candidate Selection and Organ Allocation in Liver Transplantation

Muhammad F. Dawwas1 , Alexander E. Gimson1
  • 1Liver Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Februar 2009 (online)

    Lizenzen und Reprints

ABSTRACT

Optimal candidate selection and organ allocation should offer liver transplantation to those who are sufficiently sick to justify the procedure but not too sick to benefit from it, in an order determined by patients' projected survival benefit, matching organs of sufficiently good quality to the appropriate recipients. Significant steps have been made in recent years toward devising selection and allocation criteria based on more objective and evidence-based definitions of candidate disease severity, transplant futility, organ quality, and appropriate donor-recipient matching. However, much work remains to be done in the future.

KEYWORDS

Liver transplantation - selection - allocation - cirrhosis - transplant - benefit

REFERENCES

  • 1 Merion R M, Schaubel D E, Dykstra D M, Freeman R B, Port F K, Wolfe R A. The survival benefit of liver transplantation.  Am J Transplant. 2005;  5 307-313
    CrossrefPubMedGoogle Scholar
  • 2 Freeman R B. Liver allocation: the intent-to-treat approach.  Transpl Int. 2006;  19 270-274
    CrossrefPubMedGoogle Scholar
  • 3 Schaubel D E, Sima C S, Goodrich N P, Feng S, Merion R M. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.  Am J Transplant. 2008;  8 419-425
    CrossrefPubMedGoogle Scholar
  • 4 Barshes N R, Hacker C S, Freeman Jr R B, Vierling J M, Goss J A. Justice, administrative law, and the transplant clinician: the ethical and legislative basis of a national policy on donor liver allocation.  J Contemp Health Law Policy. 2007;  23 200-230
    PubMedGoogle Scholar
  • 5 Dawwas M F, Gimson A E, Lewsey J D, Copley L P, van der Meulen J H. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States.  Gut. 2007;  56 1606-1613
    CrossrefPubMedGoogle Scholar
  • 6 Wiesner R H, Freeman R B, Mulligan D C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.  Gastroenterology. 2004;  127(5, Suppl 1) S261-S267
    CrossrefPubMedGoogle Scholar
  • 7 Merion R M, Rush S H, Dykstra D M, Goodrich N, Freeman Jr R B, Wolfe R A. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients.  Am J Transplant. 2004;  4(11) 1792-1797
    CrossrefPubMedGoogle Scholar
  • 8 Foster R, Zimmerman M, Trotter J F. Expanding donor options: marginal, living, and split donors.  Clin Liver Dis. 2007;  11 417-429
    CrossrefPubMedGoogle Scholar
  • 9 Collett D, O'Neill J, Neuberger J. Splitting livers: balancing the gain and the pain.  Transpl Int. 2008;  21 218-222
    CrossrefPubMedGoogle Scholar
  • 10 Freeman Jr R B. Survival benefit: quality versus quantity and trade-offs in developing new renal allocation systems.  Am J Transplant. 2007;  7(5) 1043-1046
    CrossrefPubMedGoogle Scholar
  • 11 Schaubel D E, Guidinger M K, Goodrich N P, Roys E C, Sima C S, Merion R M. Liver transplant benefit: liver allocation models.  Am J Transplant. 2007;  7(suppl 2) 192
    PubMedGoogle Scholar
  • 12 Freeman R B. MELD and the quality of life.  Liver Transpl. 2005;  11 134-136
    CrossrefPubMedGoogle Scholar
  • 13 Freeman Jr R B. Mortality risk, behavior, and pediatric liver allocation.  Liver Transpl. 2006;  12 12-15
    CrossrefPubMedGoogle Scholar
  • 14 Olsen J A. Theories of justice and their implications for priority setting in health care.  J Health Econ. 1997;  16 625-640
    CrossrefPubMedGoogle Scholar
  • 15 Dixon J, Welch H G. Priority setting: lessons from Oregon.  Lancet. 1991;  337 891-894
    CrossrefPubMedGoogle Scholar
  • 16 Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians.  BMJ. 1998;  317 172-175
    PubMedGoogle Scholar
  • 17 Ubel P A, Jepson C, Baron J, Mohr T, McMorrow S, Asch D A. Allocation of transplantable organs: do people want to punish patients for causing their illness?.  Liver Transpl. 2001;  7 600-607
    CrossrefPubMedGoogle Scholar
  • 18 Ratcliffe J. Public preferences for the allocation of donor liver grafts for transplantation.  Health Econ. 2000;  9 137-148
    CrossrefPubMedGoogle Scholar
  • 19 Ho D. When good organs go to bad people.  Bioethics. 2008;  22 77-83
    CrossrefPubMedGoogle Scholar
  • 20 Steinbrook R. Allocating livers–devising a fair system.  N Engl J Med. 1997;  336(6) 436-438
    CrossrefPubMedGoogle Scholar
  • 21 Ubel P A, Caplan A L. Geographic favoritism in liver transplantation–unfortunate or unfair?.  N Engl J Med. 1998;  339(18) 1322-1325
    CrossrefPubMedGoogle Scholar
  • 22 HHS/HRSA/HSB/DOT .2005 OPTN/SRTR Annual Report 1995–2004
  • 23 Organ Procurement and Transplantation Network; final rule revision of comment period and effective dates—HRSA. Extension of comment period and delay of effective date for Organ Procurement and Transplantation Network.  Fed Regist. 1998;  63 16296-16338
    PubMedGoogle Scholar
  • 24 Institute of Medicine .Analysis of waiting times. In: Committee on Organ Transplantation. Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC; National Academy Press 1999: 57-78
    Google Scholar
  • 25 Freeman R B. MELD: the holy grail of organ allocation?.  J Hepatol. 2005;  42 16-20
    PubMedGoogle Scholar
  • 26 Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.  Hepatology. 2000;  31 864-871
    CrossrefPubMedGoogle Scholar
  • 27 Kamath P S, Wiesner R, Malinchoc M et al.. A model to predict survival in patients with end-stage liver disease.  Hepatology. 2001;  33 464-470
    CrossrefPubMedGoogle Scholar
  • 28 Wiesner R, Edwards E, Freeman R et al.. Model for end-stage liver disease (MELD) and allocation of donor livers.  Gastroenterology. 2003;  124 91-96
    CrossrefPubMedGoogle Scholar
  • 29 Cholongitas E, Marelli L, Shusang V et al.. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation.  Liver Transpl. 2006;  12 1049-1061
    CrossrefPubMedGoogle Scholar
  • 30 Kanwal F, Dulai G S, Spiegel B M, Yee H F, Gralnek I M. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.  Aliment Pharmacol Ther. 2005;  21(2) 169-177
    CrossrefPubMedGoogle Scholar
  • 31 Freeman Jr R B, Wiesner R H, Roberts J P, McDiarmid S, Dykstra D M, Merion R M. Improving liver allocation: MELD and PELD.  Am J Transplant. 2004;  4(Suppl 9) 114-131
    CrossrefPubMedGoogle Scholar
  • 32 UNOS policy management policies .Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources=true Accessed October 10, 2008
  • 33 Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage.  Lancet. 1999;  354 1636-1639
    CrossrefPubMedGoogle Scholar
  • 34 Pugh R N, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of the oesophagus for bleeding oesophageal varices.  Br J Surg. 1973;  60 646-664
    CrossrefPubMedGoogle Scholar
  • 35 Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores—where are we and where should we go?.  J Hepatol. 2004;  41 344-350
    CrossrefPubMedGoogle Scholar
  • 36 Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.  J Hepatol. 2005;  42(suppl 1) S100-S107
    CrossrefPubMedGoogle Scholar
  • 37 Barber K M, Pioli S, Blackwell J E et al.. Development of a UK score for patients with end-stage liver disease.  Hepatology. 2007;  46 510A
    PubMedGoogle Scholar
  • 38 Heuman D M, Abou-Assi S G, Habib A et al.. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.  Hepatology. 2004;  40 802-810
    CrossrefPubMedGoogle Scholar
  • 39 Biggins S W, Rodriguez H J, Bacchetti P, Bass N M, Roberts J P, Terrault N A. Serum sodium predicts mortality in patients listed for liver transplantation.  Hepatology. 2005;  41 32-39
    CrossrefPubMedGoogle Scholar
  • 40 Biggins S W, Kim W R, Terrault N A et al.. Evidence-based incorporation of serum sodium concentration into MELD.  Gastroenterology. 2006;  130 1652-1660
    CrossrefPubMedGoogle Scholar
  • 41 Ruf A E, Kremers W K, Chavez L L, Descalzi V I, Podesta L G, Villamil F G. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.  Liver Transpl. 2005;  11 336-343
    CrossrefPubMedGoogle Scholar
  • 42 Londoño M C, Cárdenas A, Guevara M et al.. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.  Gut. 2007;  56(9) 1283-1290
    CrossrefPubMedGoogle Scholar
  • 43 Kim W R, Biggins S W, Kremers W K et al.. Hyponatremia and mortality among patients on the liver-transplant waiting list.  N Engl J Med. 2008;  359 1018-1026
    CrossrefPubMedGoogle Scholar
  • 44 Neuberger J, Gimson A, Davies M Liver Advisory Group et al. UK Blood and Transplant. Selection of patients for liver transplantation and allocation of donated livers in the UK.  Gut. 2008;  57 252-257
    CrossrefPubMedGoogle Scholar
  • 45 Desschans B, Van Gelder F, Van Hees D et al.. Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts.  Acta Chir Belg. 2008;  108 31-34
    PubMedGoogle Scholar
  • 46 Fontana M, Giostra E, Pilon N et al.. Liver transplantation: new organ allocation system in Switzerland.  Rev Med Suisse. 2008;  4 221-223
    PubMedGoogle Scholar
  • 47 Teixeira A C, Souza F F, Mota Gde A, Martinelli Ade L, Sankarankutty A K, Silva Ode C. Liver transplantation: expectation with MELD score for liver allocation in Brazil.  Acta Cir Bras. 2006;  21(Suppl 1) 12-14
    PubMedGoogle Scholar
  • 48 Freeman Jr R B. The model for end-stage liver disease comes of age.  Clin Liver Dis. 2007;  11 249-263
    CrossrefPubMedGoogle Scholar
  • 49 de la Mata M, Cuende N, Huet J et al.. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a Spanish multicenter experience.  Transplantation. 2006;  82 1429-1435
    CrossrefPubMedGoogle Scholar
  • 50 Huo T I, Lin H C, Lee S D. Model for end-stage liver disease and organ allocation in liver transplantation: where are we and where should we go?.  J Chin Med Assoc. 2006;  69 193-198
    CrossrefPubMedGoogle Scholar
  • 51 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
    CrossrefPubMedGoogle Scholar
  • 52 Freeman R B, Edwards E B, Harper A M. Waiting list removal rates among patients with chronic and malignant liver diseases.  Am J Transplant. 2006;  6(6) 1416-1421
    CrossrefPubMedGoogle Scholar
  • 53 Freeman R B, Mithoefer A, Ruthazer R et al.. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database.  Liver Transpl. 2006;  12(10) 1504-1511
    CrossrefPubMedGoogle Scholar
  • 54 Devlin J, O'Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.  Gut. 1999;  45(Suppl 6) VI1-VI22
    PubMedGoogle Scholar
  • 55 Yao F Y, Ferrell L, Bass N M et al.. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.  Hepatology. 2001;  33 1394-1403
    CrossrefPubMedGoogle Scholar
  • 56 Yao F Y, Bass N, Nikolai B et al.. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.  Liver Transpl. 2002;  8 873-883
    CrossrefPubMedGoogle Scholar
  • 57 Yao F Y, Xiao L, Bass N M, Kerlan R, Ascher N R, Roberts J P. Liver transplantation for hepatocellular carcinoma: Validation of the UCSF expanded criteria based on preoperative imaging.  Am J Transplant. 2007;  7 2587-2596
    CrossrefPubMedGoogle Scholar
  • 58 Bhoori S, Schiavo M, Russo A, Mazzaferro V. First-line treatment for hepatocellular carcinoma: resection or transplantation?.  Transplant Proc. 2007;  39 2271-2273
    CrossrefPubMedGoogle Scholar
  • 59 Freeman R B, Gish R G, Harper A et al.. Model for End Stage Liver Disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.  Liver Transpl. 2006;  12(suppl 3) S128-S136
    CrossrefPubMedGoogle Scholar
  • 60 Freeman Jr R B. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.  Hepatology. 2008;  47 1052-1057
    CrossrefPubMedGoogle Scholar
  • 61 Ragni M V, Eghtesad B, Schlesinger K W, Dvorchik I, Fung J J. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.  Liver Transpl. 2005;  11 1425-1430
    CrossrefPubMedGoogle Scholar
  • 62 Horslen S. Organ allocation for liver-intestine candidates.  Liver Transpl. 2004;  10(10 Suppl 2) S86-S89
    PubMedGoogle Scholar
  • 63 O'Grady J G, Alexander G J, Hayllar K M, Williams R. Early indicators of prognosis in fulminant hepatic failure.  Gastroenterology. 1989;  97 439-445
    PubMedGoogle Scholar
  • 64 Kremers W K, van IJperen M, Kim W R et al.. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.  Hepatology. 2004;  39 764-779
    CrossrefPubMedGoogle Scholar
  • 65 Yantorno S E, Kremers W K, Ruf A E, Trentadue J J, Podesta L G, Villamil F G. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure.  Liver Transpl. 2007;  13 822-828
    CrossrefPubMedGoogle Scholar
  • 66 Bernuau J, Goudeau A, Poynard T et al.. Multivariate analysis of prognostic factors in fulminant hepatitis B.  Hepatology. 1986;  6 648-651
    CrossrefPubMedGoogle Scholar
  • 67 Bernal W, Wendon J. Liver transplantation in adults with acute liver failure.  J Hepatol. 2004;  40 192-197
    CrossrefPubMedGoogle Scholar
  • 68 Sass D A, Shakil A O. Fulminant hepatic failure.  Liver Transpl. 2005;  11 594-605
    CrossrefPubMedGoogle Scholar
  • 69 Blei A T. Selection for acute liver failure: have we got it right?.  Liver Transpl. 2005;  11(11 Suppl 2) S30-S34
    CrossrefPubMedGoogle Scholar
  • 70 Jacob M, Lewsey J D, Sharpin C, Gimson A, Rela M, van der Meulen J H. Systematic review and validation of prognostic models in liver transplantation.  Liver Transpl. 2005;  11 814-825
    CrossrefPubMedGoogle Scholar
  • 71 Lewsey J D, Dawwas M, Copley L P, Gimson A, Van der Meulen J H. Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors.  Transplantation. 2006;  82 898-907
    PubMedGoogle Scholar
  • 72 Ghobrial R M, Gornbein J, Steadman R et al.. Pretransplant model to predict posttransplant survival in liver transplant patients.  Ann Surg. 2002;  236 315-322
    CrossrefPubMedGoogle Scholar
  • 73 Ioannou G N. Development and validation of a model predicting graft survival after liver transplantation.  Liver Transpl. 2006;  12 1594-1606
    CrossrefPubMedGoogle Scholar
  • 74 Plotkin J S, Scott V L, Pinna A, Dobsch B P, DeWolf A M, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation.  Liver Transpl Surg. 1996;  2 426-430
    CrossrefPubMedGoogle Scholar
  • 75 Volk M L, Hernandez J C, Lok A S, Marrero J A. A modified Charlson comorbidity index for predicting survival after liver transplantation.  Liver Transpl. 2007;  13 1515-1520
    CrossrefPubMedGoogle Scholar
  • 76 Yoo H Y, Thuluvath P J. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation.  Transplantation. 2002;  74 1007-1012
    CrossrefPubMedGoogle Scholar
  • 77 Thuluvath P J. When is diabetes mellitus a relative or absolute contraindication to liver transplantation?.  Liver Transpl. 2005;  11(11 Suppl 2) S25-S29
    CrossrefPubMedGoogle Scholar
  • 78 Pikul J, Sharpe M D, Lowndes R et al.. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients.  Transplantation. 1994;  57 469-472
    CrossrefPubMedGoogle Scholar
  • 79 Müller M J, Lautz H, Plogmann B, Burger M, Korber J, Schmidt F. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state.  Hepatology. 1992;  15 782-794
    CrossrefPubMedGoogle Scholar
  • 80 Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller M. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients.  Hepatology. 1997;  25 652-657
    CrossrefPubMedGoogle Scholar
  • 81 Bilbao I, Armadans L, Lazaro J L, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation.  Clin Transplant. 2003;  17 401-411
    CrossrefPubMedGoogle Scholar
  • 82 Dawwas M F, Gimson A E, Watson C J, Allison M E. Modeling the impact of recipient body mass index on post-liver transplant survival: a fractional polynomial approach.  Hepatology. 2008;  48(suppl) 554A
    PubMedGoogle Scholar
  • 83 Jacob M, Copley L P, Lewsey J D, Gimson A, Rela M, van der Meulen J HP. Functional status of patients before liver transplantation as a predictor of posttransplant mortality.  Transplantation. 2005;  80 52-57
    CrossrefPubMedGoogle Scholar
  • 84 Yerdel M A, Gunson B, Mirza D et al.. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.  Transplantation. 2000;  69 1873-1881
    CrossrefPubMedGoogle Scholar
  • 85 Thuluvath P J, Yoo H Y, Thompson R E. A model to predict survival at one month, one year and five years after liver transplantation based on pretransplant clinical characteristics.  Liver Transpl. 2003;  9 527-532
    CrossrefPubMedGoogle Scholar
  • 86 Desai N M, Mange K C, Crawford M D et al.. Predicting outcome after liver transplantation: utility of the model for end stage liver disease.  Transplantation. 2004;  77 99-106
    CrossrefPubMedGoogle Scholar
  • 87 Dawwas M F, Lewsey J D, Watson C J, Gimson A E. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study.  Transplantation. 2008;  , In press
    PubMedGoogle Scholar
  • 88 Londono M C, Guevara M, Rimola A et al.. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.  Gastroenterology. 2006;  130 1135-1143
    CrossrefPubMedGoogle Scholar
  • 89 Dawwas M F, Lewsey J D, Neuberger J M, Gimson A E. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study.  Liver Transpl. 2007;  13 1115-1124
    CrossrefPubMedGoogle Scholar
  • 90 Yerdel M A, Gunson B, Mirza D et al.. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.  Transplantation. 2000;  69 1873-1881
    CrossrefPubMedGoogle Scholar
  • 91 Selvaggi G, Weppler D, Nishida S et al.. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis.  Am J Transplant. 2007;  7 454-460
    CrossrefPubMedGoogle Scholar
  • 92 Bathgate A J. UK Liver Transplant Units . Recommendations for alcohol-related liver disease.  Lancet. 2006;  367 2045-2046
    CrossrefPubMedGoogle Scholar
  • 93 Murray K F, Carithers Jr R L. AASLD . AASLD practice guidelines: evaluation of the patient for liver transplantation.  Hepatology. 2005;  41 1407-1432
    CrossrefPubMedGoogle Scholar
  • 94 DiMartini A, Day N, Dew M A et al.. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease.  Liver Transpl. 2006;  12(5) 813-820
    CrossrefPubMedGoogle Scholar
  • 95 Dew M A, DiMartini A F, Steel J et al.. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.  Liver Transpl. 2008;  14(2) 159-172
    CrossrefPubMedGoogle Scholar
  • 96 Kelly M, Chick J, Gribble R et al.. Predictors of relapse to harmful alcohol after orthotopic liver transplantation.  Alcohol Alcohol. 2006;  41 278-283
    CrossrefPubMedGoogle Scholar
  • 97 De Gottardi A, Spahr L, Gelez P et al.. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.  Arch Intern Med. 2007;  167 1183-1188
    CrossrefPubMedGoogle Scholar
  • 98 Leithead J A, Ferguson J W, Hayes P C. Smoking-related morbidity and mortality following liver transplantation.  Liver Transpl. 2008;  14 1159-1164
    CrossrefPubMedGoogle Scholar
  • 99 Koch M, Banys P. Methadone is a medication, not an addiction.  Liver Transpl. 2002;  8 783-786
    CrossrefPubMedGoogle Scholar
  • 100 Charpentier K P, Mavanur A. Removing patients from the liver transplant wait list: A survey of US liver transplant programs.  Liver Transpl. 2008;  14 303-307
    CrossrefPubMedGoogle Scholar
  • 101 Trotter J F, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.  Liver Transpl. 2004;  10 995-1000
    CrossrefPubMedGoogle Scholar
  • 102 Cholongitas E, Marelli L, Kerry A et al.. Different methods of creatinine measurement significantly affect MELD scores.  Liver Transpl. 2007;  13(4) 523-529
    CrossrefPubMedGoogle Scholar
  • 103 Cholongitas E, Marelli L, Kerry A et al.. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias.  Am J Transplant. 2007;  7(3) 685-692
    CrossrefPubMedGoogle Scholar
  • 104 Sherman D S, Fish D N, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls.  Am J Kidney Dis. 2003;  41 269-278
    CrossrefPubMedGoogle Scholar
  • 105 Ravaioli M, Masetti M, Ridolfi L et al.. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.  Transplantation. 2007;  83(7) 919-924
    CrossrefPubMedGoogle Scholar
  • 106 Trotter J F, Olson J, Lefkowitz J, Smith A D, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.  Am J Transplant. 2007;  7(6) 1624-1628
    CrossrefPubMedGoogle Scholar
  • 107 Tripodi A, Chantarangkul V, Primignani M et al.. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.  Hepatology. 2007;  46(2) 520-527
    CrossrefPubMedGoogle Scholar
  • 108 Bellest L, Eschwège V, Poupon R, Chazouillères O, Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.  Hepatology. 2007;  46(2) 528-534
    CrossrefPubMedGoogle Scholar
  • 109 Tripodi A, Chantarangkul V, Mannucci P M. The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions.  J Thromb Haemost. 2008;  6 243-248
    CrossrefPubMedGoogle Scholar
  • 110 Saab S, Ibrahim A B, Shpaner A et al.. MELD fails to measure quality of life in liver transplant candidates.  Liver Transpl. 2005;  11 218-223
    CrossrefPubMedGoogle Scholar
  • 111 Yoo H Y, Edwin D, Thuluvath P J. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, neuropsychometric testing, and ascites.  Am J Gastroenterol. 2003;  98 1395-1399
    CrossrefPubMedGoogle Scholar
  • 112 Huo T I, Lin H C, Wu J C et al.. Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction.  Transplantation. 2005;  80(10) 1414-1418
    CrossrefPubMedGoogle Scholar
  • 113 Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.  J Clin Gastroenterol. 2007;  41 922-926
    CrossrefPubMedGoogle Scholar
  • 114 Yu J W, Wang G Q, Li S C. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system.  J Gastroenterol Hepatol. 2006;  21 1519-1524
    CrossrefPubMedGoogle Scholar
  • 115 Sharma P, Schaubel D E, Sima C S, Merion R M, Lok A S. Re-weighting the model for end-stage liver disease score components.  Gastroenterology. 2008;  135 1575-1581
    CrossrefPubMedGoogle Scholar
  • 116 Ripoll C, Bañares R, Rincón D et al.. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era.  Hepatology. 2005;  42(4) 793-801
    CrossrefPubMedGoogle Scholar
  • 117 Said A, Williams J, Holden J et al.. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.  J Hepatol. 2004;  40(6) 897-903
    CrossrefPubMedGoogle Scholar
  • 118 Luca A, Angermayr B, Bertolini G et al.. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.  Liver Transpl. 2007;  13 1174-1180
    CrossrefPubMedGoogle Scholar
  • 119 Stewart C A, Malinchoc M, Kim W R, Kamath P S. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.  Liver Transpl. 2007;  13(10) 1366-1371
    CrossrefPubMedGoogle Scholar
  • 120 Heuman D M, Mihas A A, Habib A et al.. MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy.  Liver Transpl. 2007;  13(1) 30-37
    CrossrefPubMedGoogle Scholar
  • 121 Feng S, Goodrich N P, Bragg-Gresham J L et al.. Characteristics associated with liver graft failure: the concept of a donor risk index.  Am J Transplant. 2006;  6 783-790
    CrossrefPubMedGoogle Scholar
  • 122 Dawwas M F, Collett D, Barber K, Watson C J, Neuberger J M. Developing a liver transplantation donor risk index in a national registry.  Hepatology. 2007;  46(suppl 1) 235A
    PubMedGoogle Scholar
  • 123 Dawwas M F, Collett D, Barber K, Watson C J, Neuberger J N, Gimson A E. Should donor organs and recipients be matched in liver transplantation? An analysis of the United Kingdom and Ireland Liver Transplant Database.  Hepatology. 2007;  46(suppl 1) 516A
    PubMedGoogle Scholar
  • 124 Ravaioli M, Grazi G L, Ercolani G et al.. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.  Transplantation. 2006;  81 525-530
    CrossrefPubMedGoogle Scholar
  • 125 Segev D L, Maley W R, Simpkins C E et al.. Minimizing risk associated with elderly liver donors by matching to preferred recipients.  Hepatology. 2007;  46 1907-1918
    CrossrefPubMedGoogle Scholar
  • 126 Dawwas M F, Allison M E, Watson C J, Gimson A E. Diabetic donor organs and survival among HCV + liver transplant recipients: a further piece in the jigsaw.  Hepatology. 2008;  48(suppl) 19A
    PubMedGoogle Scholar
  • 127 Dawwas M F, Watson C J, Gimson A E. Liver transplant allocation to patients with hepatocellular carcinoma.  Hepatology. 2008;  48(suppl) 104A
    PubMedGoogle Scholar
  • 128 Amin M G, Wolf M P, Tenbrook M A et al.. The underutilization of expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis.  Liver Transpl. 2004;  10 1468-1475
    CrossrefPubMedGoogle Scholar
  • 129 Haydon G H, Hiltunen Y, Lucey M R et al.. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation.  Transplantation. 2005;  79 213-218
    CrossrefPubMedGoogle Scholar
  • 130 Cucchetti A, Vivarelli M, Heaton N D et al.. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.  Gut. 2007;  56 253-258
    CrossrefPubMedGoogle Scholar
  • 131 Shechter S M, Bryce C L, Alagoz O et al.. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.  Med Decis Making. 2005;  25 199-209
    CrossrefPubMedGoogle Scholar
  • 132 Thompson D, Waisanen L, Wolfe R, Merion R M, McCullough K, Rodgers A. Simulating the allocation of organs for transplantation.  Health Care Manage Sci. 2004;  7 331-338
    CrossrefPubMedGoogle Scholar

Alexander E GimsonM.D. 

Liver Transplant Unit, Box 210, Addenbrooke's Hospital, Hills Road

Cambridge CB2 2QQ, United Kingdom

eMail: alexander.gimson@addenbrookes.nhs.uk

      >